Clinical trials
Schizophrenia trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 6 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 7 |
| Norwegian University of Science and Technology | 6 |
| Haukeland University Hospital | 4 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| St. Olavs Hospital | 2 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Madeleine Elisabeth Angelsen | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Sara Poletti | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 35 |
| Psychotic Disorders | 13 |
| Bipolar Disorder | 8 |
| Mental Disorders | 8 |
| Cardiovascular Diseases | 4 |
| Depressive Disorder | 2 |
| Mood Disorders | 2 |
| Affective Disorders, Psychotic | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.